$RXPC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RADIENT PHARMACEUTICALS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RADIENT PHARMACEUTICALS Corp. Get notifications about new insider transactions in RADIENT PHARMACEUTICALS Corp for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 03 2011 | RXPC | RADIENT PHARMACEUT ... | ALPHA CAPITAL ANSTALT | Sell | S | 0.01 | 5,052,094 | 30,818 | 3,690,218 | 8.7 M to 3.7 M (-57.79 %) | |
Nov 03 2011 | RXPC | RADIENT PHARMACEUT ... | ALPHA CAPITAL ANSTALT | Sell | S | 0.01 | 1,400,000 | 10,640 | 8,742,312 | 10.1 M to 8.7 M (-13.80 %) | |
Jul 25 2011 | RXPC | RADIENT PHARMACEUT ... | ALPHA CAPITAL ANSTALT | Sell | S | 0.10 | 1,460,688 | 142,563 | 10,142,312 | 11.6 M to 10.1 M (-12.59 %) | |
Jul 25 2011 | RXPC | RADIENT PHARMACEUT ... | WHALEHAVEN CAPITAL FUND LTD | Sell | S | 0.08 | 233,000 | 19,572 | 7,475,000 | 7.7 M to 7.5 M (-3.02 %) | |
Jul 25 2011 | RXPC | RADIENT PHARMACEUT ... | WHALEHAVEN CAPITAL FUND LTD | Sell | S | 0.08 | 905,000 | 73,667 | 7,708,000 | 8.6 M to 7.7 M (-10.51 %) | |
Jul 25 2011 | RXPC | RADIENT PHARMACEUT ... | WHALEHAVEN CAPITAL FUND LTD | Sell | S | 0.11 | 225,000 | 25,200 | 8,613,000 | 8.8 M to 8.6 M (-2.55 %) | |
Jul 25 2011 | RXPC | RADIENT PHARMACEUT ... | WHALEHAVEN CAPITAL FUND LTD | Sell | S | 0.12 | 59,000 | 7,198 | 8,838,000 | 8.9 M to 8.8 M (-0.66 %) | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Option Exercise | A | 0.75 | 50,000 | 37,500 | 140,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Option Exercise | A | 0.75 | 50,000 | 37,500 | 90,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Option Exercise | A | 0.75 | 12,973 | 9,730 | 40,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Option Exercise | A | 0.75 | 27,027 | 20,270 | 27,027 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Sell | J | 0.00 | 100,000 | 0 | 0 | 100 K to 0 (-100.00 %) |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 200,000 | 150,000 | 446,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 90,000 | 67,500 | 246,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 120,000 | 90,000 | 156,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 36,000 | 27,000 | 36,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | J | 0.00 | 200,000 | 0 | 1,100 | 201.1 K to 1.1 K (-99.45 %) |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M. III | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 180,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M. III | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 130,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M. III | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 80,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M. III | Director | Option Exercise | A | 0.75 | 30,000 | 22,500 | 30,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 0.75 | 20,000 | 15,000 | 80,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 0.75 | 20,000 | 15,000 | 60,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 0.75 | 20,000 | 15,000 | 40,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 0.75 | 20,000 | 15,000 | 20,000 | |
Jan 15 2009 | RXPC | RADIENT PHARMACEUT ... | BOSWELL MICHAEL ROBERT | Director | Grant | A | 0.72 | 40,000 | 28,800 | 40,000 | 0 to 40 K |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Chief Executive Off ... | Grant | A | 0.72 | 200,000 | 144,000 | 201,100 | 1.1 K to 201.1 K (+18,181.82 %) |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | Zheng Fang | Grant | A | 0.72 | 100,000 | 72,000 | 700,000 | 600 K to 700 K (+16.67 %) | |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Grant | A | 0.72 | 100,000 | 72,000 | 100,000 | 0 to 100 K |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M. III | Director | Grant | A | 0.72 | 40,000 | 28,800 | 44,039 | 4 K to 44 K (+990.34 %) |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | Jia Minghui | Director | Grant | A | 0.72 | 100,000 | 72,000 | 701,000 | 601 K to 701 K (+16.64 %) |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Grant | A | 0.72 | 40,000 | 28,800 | 56,494 | 16.5 K to 56.5 K (+242.51 %) |
Jul 25 2008 | RXPC | RADIENT PHARMACEUT ... | Jia Minghui | Director | Buy | P | 2.90 | 1,000 | 2,900 | 601,000 | 600 K to 601 K (+0.17 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M. III | Director | Buy | P | 2.65 | 1,000 | 2,653 | 4,039 | 3 K to 4 K (+32.91 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Buy | P | 2.70 | 100 | 270 | 19,767 | 19.7 K to 19.8 K (+0.51 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Buy | P | 2.61 | 9,000 | 23,481 | 19,667 | 10.7 K to 19.7 K (+84.37 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Buy | P | 2.68 | 900 | 2,412 | 10,667 | 9.8 K to 10.7 K (+9.21 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Buy | P | 2.68 | 1,000 | 2,684 | 1,100 | 100 to 1.1 K (+1,000.00 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Buy | P | 2.65 | 1,000 | 2,650 | 16,494 | 15.5 K to 16.5 K (+6.45 %) |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M. III | Director | Option Exercise | A | 3.45 | 50,000 | 172,500 | 239,000 | |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 3.45 | 20,000 | 69,000 | 119,000 | |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 3.45 | 200,000 | 690,000 | 485,000 | |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | Zheng Fang | 10% Owner | Option Exercise | A | 3.45 | 50,000 | 172,500 | 270,000 | |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | Jia Minghui | Director | Option Exercise | A | 3.45 | 50,000 | 172,500 | 270,000 | |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Option Exercise | A | 3.45 | 300,000 | 1,035,000 | 1,031,000 | |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Option Exercise | A | 3.45 | 50,000 | 172,500 | 140,000 | |
Feb 06 2008 | RXPC | RADIENT PHARMACEUT ... | Jade Capital Group LTD | 10% Owner | Gift | G | 0.00 | 86,078 | 0 | 86,078 | 172.2 K to 86.1 K (-50.00 %) |
Jan 22 2008 | RXPC | RADIENT PHARMACEUT ... | Jade Capital Group LTD | 10% Owner | Gift | G | 0.00 | 190,150 | 0 | 1,058,750 | 1.2 M to 1.1 M (-15.23 %) |
Jul 26 2007 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Option Exercise | M | 2.40 | 13,000 | 31,200 | 31,200 | |
Jul 26 2007 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Sell | S | 3.01 | 13,000 | 39,130 | 3,039 | 16 K to 3 K (-81.05 %) |
Jul 26 2007 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Buy | M | 2.40 | 13,000 | 31,200 | 16,039 | 3 K to 16 K (+427.77 %) |
Jul 26 2007 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Option Exercise | M | 2.40 | 70,000 | 168,000 | 731,002 | |
Jul 26 2007 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Sell | S | 3.01 | 62,333 | 187,622 | 9,767 | 72.1 K to 9.8 K (-86.45 %) |
Jul 26 2007 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Buy | M | 2.40 | 70,000 | 168,000 | 72,100 | 2.1 K to 72.1 K (+3,333.33 %) |
Jul 02 2007 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | M | 2.40 | 13,000 | 31,200 | 99,000 | |
Jul 02 2007 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Buy | M | 2.40 | 13,000 | 31,200 | 15,554 | 2.6 K to 15.6 K (+509.01 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | M | 2.40 | 13,000 | 31,200 | 285,000 | |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.86 | 300 | 1,158 | 0 | 300 to 0 (-100.00 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.80 | 1,700 | 6,460 | 300 | 2 K to 300 (-85.00 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.79 | 125 | 474 | 2,000 | 2.1 K to 2 K (-5.88 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.78 | 875 | 3,308 | 2,125 | 3 K to 2.1 K (-29.17 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.76 | 200 | 752 | 3,000 | 3.2 K to 3 K (-6.25 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.75 | 500 | 1,875 | 3,200 | 3.7 K to 3.2 K (-13.51 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.74 | 300 | 1,122 | 3,700 | 4 K to 3.7 K (-7.50 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.71 | 300 | 1,113 | 4,000 | 4.3 K to 4 K (-6.98 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.70 | 2,200 | 8,140 | 4,300 | 6.5 K to 4.3 K (-33.85 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.66 | 500 | 1,830 | 6,500 | 7 K to 6.5 K (-7.14 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.65 | 300 | 1,095 | 7,000 | 7.3 K to 7 K (-4.11 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.62 | 500 | 1,810 | 7,300 | 7.8 K to 7.3 K (-6.41 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.60 | 1,600 | 5,760 | 7,800 | 9.4 K to 7.8 K (-17.02 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.58 | 200 | 716 | 9,400 | 9.6 K to 9.4 K (-2.08 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.57 | 600 | 2,142 | 9,600 | 10.2 K to 9.6 K (-5.88 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.56 | 600 | 2,136 | 10,200 | 10.8 K to 10.2 K (-5.56 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.55 | 500 | 1,775 | 10,800 | 11.3 K to 10.8 K (-4.42 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.54 | 500 | 1,770 | 11,300 | 11.8 K to 11.3 K (-4.24 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.53 | 1,200 | 4,236 | 11,800 | 13 K to 11.8 K (-9.23 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Buy | M | 2.40 | 13,000 | 31,200 | 13,000 | 0 to 13 K |
Jun 11 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 4.06 | 90,000 | 365,400 | 90,000 | |
Jun 11 2007 | RXPC | RADIENT PHARMACEUT ... | Ariura Akio | Chief Financial Off ... | Option Exercise | A | 4.06 | 50,000 | 203,000 | 50,000 | |
Jun 11 2007 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 4.06 | 20,000 | 81,200 | 20,000 | |
Jun 11 2007 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Option Exercise | A | 4.06 | 172,000 | 698,320 | 172,000 | |
Jun 11 2007 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Option Exercise | A | 4.06 | 50,000 | 203,000 | 50,000 | |
Mar 01 2006 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Option Exercise | A | 0.57 | 150,000 | 85,500 | 150,000 | |
Mar 01 2006 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.57 | 180,000 | 102,600 | 180,000 | |
Mar 01 2006 | RXPC | RADIENT PHARMACEUT ... | ROSENTHALE MARVIN E | Director | Option Exercise | A | 0.57 | 100,000 | 57,000 | 100,000 | |
Mar 01 2006 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Option Exercise | A | 0.57 | 300,000 | 171,000 | 300,000 | |
Mar 01 2006 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 0.57 | 100,000 | 57,000 | 100,000 | |
Feb 01 2005 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Option Exercise | A | 0.83 | 300,000 | 249,000 | 300,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.93 | 55,000 | 51,150 | 55,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | ROSENTHALE MARVIN E | Director | Option Exercise | A | 0.93 | 55,000 | 51,150 | 55,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Option Exercise | A | 0.93 | 55,000 | 51,150 | 55,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Option Exercise | A | 0.93 | 55,000 | 51,150 | 55,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Option Exercise | A | 0.93 | 250,000 | 232,500 | 250,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 0.93 | 55,000 | 51,150 | 55,000 | |
Apr 20 2004 | RXPC | RADIENT PHARMACEUT ... | ROSTEN ARTHUR S | CFO | Option Exercise | A | 0.97 | 5,000 | 4,850 | 5,000 | |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | THOMPSON WILLIAM M | Director | Option Exercise | A | 1.23 | 200,000 | 246,000 | 200,000 | |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | ROSTEN ARTHUR S | CFO | Option Exercise | A | 1.23 | 70,000 | 86,100 | 70,000 | |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | ROSENTHALE MARVIN E | Director | Option Exercise | A | 1.23 | 100,000 | 123,000 | 100,000 | |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 1.23 | 100,000 | 123,000 | 100,000 | |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | DREHER GARY L | President & CEO | Option Exercise | A | 1.23 | 700,000 | 861,000 | 700,000 | |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | ARQUILLA EDWARD R | Director | Option Exercise | A | 1.23 | 100,000 | 123,000 | 100,000 |
Page: 1